SettleĀ® Injectable

1.5 ml Vial

NOVAVIVE USA INC

Patterson Item #:

07-849-7412

Manufacturer Item #:

5555

Active Ingredient:
Emulsion of purified mycobacterium cell walls
Volume:
1.5 ml
Package Quantity:
1/Pkg
Presentation:
Liquid
Container Type:
Vial
Delivery Type:
Injection

Description

SETTLEĀ® is immunotherapeutic licensed to treat equine endometritis - one of the root causes of poor conception rates. Supportive research has demonstrated positive results not only for rapidly resolving uterine infection, but also improving overall uterine health.
  • A new technological approach for a costly, industry-wide reproduction problem
  • Normalizes sub-optimal responses to infection and endometritis in problem mares
  • Proven both safe and effective in U.S. mares over past two breeding seasons
  • Works as a stand alone treatment or hand-in-hand with other therapies to synergistically improve treatment outcomes
  • USDA-licensed to treat equine endometritis caused by Streptococcus zooepidemicus
  • Stimulates the mare’s own immune system, helping it to recognize, respond and begin repair of damaged tissue and infection
  • Addresses broad range of endometritis issue: infection, inflammation and healing
  • Permits earliest return of the equine uterus to a “breeding-ready status”
  • Intravenous or intr-uterine administration routes provide similar therapeutic results
DEA
Hazmat - Chargeable
Ice
List 1
MSDS
Previously Purchased
Hazmat - No Charge
Pedigree
Prescription
Promotion
Formulary
New Arrivals